Is It Too Late to Buy CRISPR Therapeutics Stock?
https://www.fool.com/investing/2024/03/16/is-it-too-late-to-buy-crispr-therapeutics-stock/?source=iedfolrf0000001
Mar 16, 2024 - The biotech has been making a lot of noise since late last year.
0
Charles River (CRL) Forges Collaboration With Ship of Theseus
https://www.zacks.com/stock/news/2253832/charles-river-crl-forges-collaboration-with-ship-of-theseus?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2253832
Apr 11, 2024 - Charles River (CRL) is set to perform plasmid production for Ship of Theseus.
0
bluebird (BLUE) Underperforms Industry YTD Amid Challenges
https://www.zacks.com/stock/news/2256355/bluebird-blue-underperforms-industry-ytd-amid-challenges?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2256355
Apr 16, 2024 - bluebird (BLUE) plunges 25% year to date as it struggles to fuel the growth of its complex and expensive gene therapies.
0
bluebird (BLUE) Tops on Q1 Sales, Zynteglo Progresses Well
https://www.zacks.com/stock/news/2272460/bluebird-blue-tops-on-q1-sales-zynteglo-progresses-well?cid=CS-ZC-FT-analyst_blog|earnings_article-2272460
May 10, 2024 - bluebird (BLUE) beats sales estimates in the first quarter on increased Zynteglo product revenues. The company is on track with the ongoing launch of its gene therapies.
0
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
https://www.fool.com/investing/2024/05/14/2-healthcare-stocks-to-buy-and-hold-for-great-long/?source=iedfolrf0000001
May 14, 2024 - These healthcare stocks offer completely different approaches to long-term investment gains.
0
Pages: 1
Page 1